MetaCap

Verrica Pharmaceuticals Insider Trades

NASDAQ: VRCAHealth CareBiotechnology: Pharmaceutical PreparationsUSD

2.74-0.145 (-5.03%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

Last 12 months

Purchases
12 · $18.18M
Sales
0 · $0
Shares bought / sold
4.28M / 0
Net activity
Net buying $18.2 million

Verrica Pharmaceuticals insider activity

Over the last 12 months, Verrica Pharmaceuticals insiders reported 13 transactions on SEC Form 4: 12 open-market purchases and 0 sales. Insiders bought $18.2 million and sold $0 worth of stock, for net insider buying of $18.2 million. The most recent filing shows Rosenberg Noah L. (CMO) buying 2,030 shares at $4.92 on Aug 18, 2026.

Insider sales are common for compensation, tax and diversification reasons, while open-market purchases are rarer; tracking both helps put VRCA's ownership changes in context.

Summary generated from market data by MetaCap's automated system. Methodology

VRCA insider transactions

Verrica Pharmaceuticals insider transactions
DateInsiderTypeSharesValueFiling
Aug 18, 2026Kirby John J.Interim CFOBuy5,000$24.65KForm 4
Aug 18, 2026Rosenberg Noah L.CMOBuy2,030$9.99KForm 4
Aug 17, 2026Rosenberg Noah L.CMOBuy4,200$20.62KForm 4
Aug 17, 2026Zawitz DavidChief Operating OfficerBuy6,000$29.88KForm 4
Aug 17, 2026Rieger JaysonCEO and PresidentBuy5,000$24.55KForm 4
Aug 14, 2026Rieger JaysonCEO and PresidentBuy20,000$101.20KForm 4
Dec 23, 2025Kirby John J.Interim CFOAward10,000—Form 4
Nov 25, 2025Rieger JaysonCEO and PresidentBuy94,311$400.11KForm 4
Nov 25, 2025Zawitz DavidChief Operating OfficerBuy10,000$42.42KForm 4
Nov 25, 2025Kirby John J.Interim CFOBuy3,536$15.00KForm 4
Nov 25, 2025Manning Paul BDirectorBuy2,750,762$11.67MForm 4
Nov 25, 2025Manning Paul BDirectorBuy1,375,380$5.84MForm 4
Nov 25, 2025Rosenberg Noah L.CMOBuy2,357$10.00KForm 4
Mar 17, 2025Hayes Christopher G.CHIEF LEGAL OFFICERSale4,315$2.80KForm 4
Nov 26, 2024Rieger JaysonCEO and PresidentGift50,000—Form 4
Nov 26, 2024Manning Paul BDirectorGift450,000—Form 4
Nov 26, 2024Stalfort John A IIIDirectorGift50,000—Form 4
Nov 22, 2024Rieger JaysonCEO and PresidentBuy280,898—Form 4
Nov 22, 2024Manning Paul BDirectorBuy4,494,382—Form 4
Nov 22, 2024Manning Paul BDirectorBuy18,426,966—Form 4
Nov 22, 2024Stalfort John A IIIDirectorBuy1,123,595—Form 4
Nov 6, 2024Kirby John J.Interim CFOAward54,267—Form 4
Sep 19, 2024Manning Paul BDirectorGift891,870—Form 4
Sep 19, 2024Manning Paul BDirectorGift891,870—Form 4
Sep 19, 2024Manning Paul BDirectorGift891,870—Form 4
Sep 19, 2024Manning Paul BDirectorGift2,675,611—Form 4
Aug 27, 2024Goldenberg GaryChief Medical OfficerSale3,601$8.86KForm 4
Aug 27, 2024Hayes Christopher G.CHIEF LEGAL OFFICERSale9,530$23.44KForm 4
Aug 26, 2024Goldenberg GaryChief Medical OfficerSale9,888$26.30KForm 4
Aug 26, 2024Hayes Christopher G.CHIEF LEGAL OFFICERSale26,183$69.65KForm 4
Aug 24, 2023Bonaccorso JoeCHIEF COMMERCIAL OFFICERAward125,000—Form 4
Aug 24, 2023Kohler TerryCHIEF FINANCIAL OFFICERAward125,000—Form 4
Aug 24, 2023Hayes Christopher G.CHIEF LEGAL OFFICERAward150,000—Form 4
Aug 24, 2023White TedPRESIDENT AND CEOAward150,000—Form 4
Aug 24, 2023Goldenberg GaryChief Medical OfficerAward50,000—Form 4

Transaction codes follow SEC Form 4: P = open-market purchase, S = open-market sale, A = grant or award, M = option exercise, F = shares withheld for taxes. About Form 4

Related